MMI Q1 2026 Earnings Loss Wider Than Expected as Revenue Remains Unclear Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline DLB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Pasithea Therapeutics Corp KTTA Q1 2026 Earnings Significant EPS Beat Despite Zero Revenue OLLI Q1 2026 Earnings EPS Misses Estimates Despite Solid Performance Shares Dip GETY Q1 2026 Earnings EPS Misses by Wide Margin Stock Gains on Strategic Momentum